New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
April 9, 2014
08:15 EDTAMPEAmpio's Ampion shows positive results in arthritis study extension
Ampio announced results of the 20 weeks extension of the Ampion SPRING study to be presented at the Western Orthopedic Association Conference in July. This 20-week extension of a multicenter study evaluated the safety and efficacy of a single intra-articular injection of Ampion treatment of inflammation-associated pain in symptomatic OA of the knee. At 20 weeks, the percentage of patients in the moderate-to-severe subgroup who reported a reduction in pain was significantly higher for patients who received Ampion - 50% - compared to those who received vehicle control - 25% -. Similar rates and severity of adverse events were observed in the Ampion and vehicle control groups. A single injection of Ampion was associated with sustained improvements in knee pain over 20 weeks.
News For AMPE From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
November 19, 2014
07:11 EDTAMPESociety for Free Radical Biology and Medicine to hold annual meeting
Subscribe for More Information
November 12, 2014
09:21 EDTAMPEOn The Fly: Pre-market Movers
Subscribe for More Information
08:12 EDTAMPEAmpio's Ampion vials will be manufactured in 1Q15
Subscribe for More Information
08:11 EDTAMPEAmpio updates status of clinical trials and manufacturing facility
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use